{"id":"https://openalex.org/W4214931192","doi":"https://doi.org/10.1017/9781108975759.016","title":"ATRI and ACTC: Academic Programs to Accelerate Alzheimer\u2019s Disease Drug Development","display_name":"ATRI and ACTC: Academic Programs to Accelerate Alzheimer\u2019s Disease Drug Development","publication_year":2022,"publication_date":"2022-03-03","ids":{"openalex":"https://openalex.org/W4214931192","doi":"https://doi.org/10.1017/9781108975759.016"},"language":"en","primary_location":{"id":"doi:10.1017/9781108975759.016","doi":"https://doi.org/10.1017/9781108975759.016","is_oa":false,"landing_page_url":"https://doi.org/10.1017/9781108975759.016","pdf_url":null,"source":{"id":"https://openalex.org/S4306462995","display_name":"Cambridge University Press eBooks","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4310311721","host_organization_name":"Cambridge University Press","host_organization_lineage":["https://openalex.org/P4310311721","https://openalex.org/P4310311702"],"host_organization_lineage_names":["Cambridge University Press","University of Cambridge"],"type":"ebook platform"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Alzheimer's Disease Drug Development","raw_type":"book-chapter"},"volume":{"id":"https://openalex.org/W4214852857","display_name":"Alzheimer's Disease Drug Development"},"type":"book-chapter","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5034225628","display_name":"Paul S. S Aisen","orcid":"https://orcid.org/0000-0002-2896-5838","observed_orcids":["https://orcid.org/0000-0002-2896-5838"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Paul S. Aisen","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068057129","display_name":"Rema Raman","orcid":"https://orcid.org/0000-0002-4096-6390","observed_orcids":["https://orcid.org/0000-0002-4096-6390"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Rema Raman","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026799001","display_name":"Michael S. Rafii","orcid":"https://orcid.org/0000-0003-2640-2094","observed_orcids":["https://orcid.org/0000-0003-2640-2094"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Michael S. Rafii","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001795846","display_name":"Reisa Anne Sperling","orcid":"https://orcid.org/0000-0003-1535-6133","observed_orcids":["https://orcid.org/0000-0003-1535-6133"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Reisa A. Sperling","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5110342810","display_name":"Ronald Carl Petersen","orcid":"https://orcid.org/0000-0002-8178-6601","observed_orcids":["https://orcid.org/0000-0002-8178-6601"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ronald C. Petersen","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.4737,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":{"value":0.54816286,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":null,"issue":null,"first_page":"177","last_page":"189"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":0.9657999873161316,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":0.9657999873161316,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10009","display_name":"Dementia and Cognitive Impairment Research","score":0.02930000051856041,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10582","display_name":"Ethics in Clinical Research","score":0.0020000000949949026,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/alzheimer-s-disease","display_name":"Alzheimer's disease","score":0.8519999980926514},{"id":"https://openalex.org/keywords/drug-development","display_name":"drug development","score":0.9610000252723694},{"id":"https://openalex.org/keywords/atri","display_name":"Atri","score":0.6190000176429749},{"id":"https://openalex.org/keywords/clinical-trial-design","display_name":"clinical trial design","score":0.6949999928474426},{"id":"https://openalex.org/keywords/biomarkers","display_name":"biomarkers","score":0.7039999961853027},{"id":"https://openalex.org/keywords/regulatory-pathways","display_name":"regulatory pathways","score":0.7239999771118164},{"id":"https://openalex.org/keywords/public-private-partnerships","display_name":"public-private partnerships","score":0.9649999737739563},{"id":"https://openalex.org/keywords/national-institute-on-aging","display_name":"National Institute on Aging","score":0.753000020980835}],"concepts":[{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.45926156640052795},{"id":"https://openalex.org/C64903051","wikidata":"https://www.wikidata.org/wiki/Q2198549","display_name":"Drug development","level":3,"score":0.4283711910247803},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.37754493951797485},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.3661538362503052},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.35708528757095337},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.16400259733200073}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1017/9781108975759.016","doi":"https://doi.org/10.1017/9781108975759.016","is_oa":false,"landing_page_url":"https://doi.org/10.1017/9781108975759.016","pdf_url":null,"source":{"id":"https://openalex.org/S4306462995","display_name":"Cambridge University Press eBooks","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4310311721","host_organization_name":"Cambridge University Press","host_organization_lineage":["https://openalex.org/P4310311721","https://openalex.org/P4310311702"],"host_organization_lineage_names":["Cambridge University Press","University of Cambridge"],"type":"ebook platform"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Alzheimer's Disease Drug Development","raw_type":"book-chapter"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.8371999859809875}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":61,"referenced_works":["https://openalex.org/W8541533","https://openalex.org/W166560457","https://openalex.org/W950120787","https://openalex.org/W1164896577","https://openalex.org/W1725757145","https://openalex.org/W1953027527","https://openalex.org/W1972300483","https://openalex.org/W1980150973","https://openalex.org/W1983349802","https://openalex.org/W1984903870","https://openalex.org/W1990805071","https://openalex.org/W1996776294","https://openalex.org/W1998142925","https://openalex.org/W2000917982","https://openalex.org/W2015400724","https://openalex.org/W2015484447","https://openalex.org/W2021964708","https://openalex.org/W2029506047","https://openalex.org/W2030316944","https://openalex.org/W2030726478","https://openalex.org/W2048257197","https://openalex.org/W2051737015","https://openalex.org/W2053338655","https://openalex.org/W2061602279","https://openalex.org/W2062546772","https://openalex.org/W2095157185","https://openalex.org/W2107820540","https://openalex.org/W2110759468","https://openalex.org/W2112579276","https://openalex.org/W2122328291","https://openalex.org/W2142439044","https://openalex.org/W2147048440","https://openalex.org/W2158087247","https://openalex.org/W2165136235","https://openalex.org/W2275089335","https://openalex.org/W2314133009","https://openalex.org/W2326200998","https://openalex.org/W2346833359","https://openalex.org/W2398267441","https://openalex.org/W2564942951","https://openalex.org/W2593272302","https://openalex.org/W2626001339","https://openalex.org/W2785757836","https://openalex.org/W2802358177","https://openalex.org/W2807021305","https://openalex.org/W2887141826","https://openalex.org/W2888918636","https://openalex.org/W2937097483","https://openalex.org/W2939644735","https://openalex.org/W2962964542","https://openalex.org/W2964173965","https://openalex.org/W2980623457","https://openalex.org/W3014487247","https://openalex.org/W3035782677","https://openalex.org/W3036188263","https://openalex.org/W3047582987","https://openalex.org/W3080733801","https://openalex.org/W3081319424","https://openalex.org/W3081469601","https://openalex.org/W3105808417","https://openalex.org/W6712129461"],"related_works":["https://openalex.org/W2990800666","https://openalex.org/W4387675480","https://openalex.org/W3080753361","https://openalex.org/W4214851307","https://openalex.org/W4390192831","https://openalex.org/W2416258327","https://openalex.org/W4400644043","https://openalex.org/W4214869715","https://openalex.org/W4214835773","https://openalex.org/W2102138811"],"abstract_inverted_index":{"Academic":[0],"investigators":[1],"have":[2],"played":[3],"key":[4],"roles":[5],"in":[6,19,87,136,143],"Alzheimer\u2019s":[7,57,65],"disease":[8],"drug":[9],"development.":[10],"This":[11],"work":[12],"has":[13,48],"been":[14],"highly":[15],"collaborative,":[16],"with":[17,55,92],"innovations":[18,128],"trial":[20,79,113,137,145],"design,":[21,146],"population":[22],"characteristics,":[23],"outcome":[24],"measures,":[25],"biomarker":[26],"utilization":[27],"and":[28,39,59,81,100,110,134,147],"regulatory":[29],"pathways":[30],"arising":[31],"from":[32,106],"interactions":[33],"among":[34],"academics,":[35],"industry":[36],"scientists,":[37],"regulators,":[38],"other":[40,60],"stakeholders.":[41],"The":[42,63],"National":[43],"Institute":[44],"on":[45,78,132],"Aging":[46],"(NIA)":[47],"funded":[49],"much":[50],"of":[51,84,95,118,140,152],"this":[52],"work,":[53],"along":[54],"the":[56,82,93,101,108,149],"Association":[58],"philanthropic":[61],"organizations.":[62],"NIA":[64],"Clinical":[66],"Trials":[67],"Consortium":[68],"(ACTC)":[69],"supports":[70],"a":[71,116,130],"nationwide":[72],"infrastructure":[73],"to":[74],"continue":[75],"academic":[76],"efforts":[77],"methodology":[80],"implementation":[83],"innovative":[85],"studies":[86],"age-related":[88],"neurodegenerative":[89],"disorders.":[90],"ACTC,":[91],"University":[94,99],"Southern":[96],"California,":[97],"Harvard":[98],"Mayo":[102],"Clinic,":[103],"expert":[104],"trialists":[105],"across":[107],"country":[109],"35":[111],"primary":[112],"sites,":[114],"conducts":[115],"number":[117],"multicenter":[119],"randomized":[120],"controlled":[121],"trials.":[122],"Public-private":[123],"partnerships":[124],"are":[125],"encouraged.":[126],"Additional":[127],"include":[129],"focus":[131],"diversity":[133],"inclusion":[135],"recruitment,":[138],"involvement":[139],"research":[141],"participants":[142],"guiding":[144],"training":[148],"next":[150],"generation":[151],"trialists.":[153]},"counts_by_year":[{"year":2022,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2022-03-05T00:00:00"}